Today: 20 March 2026
Browse Category

NASDAQ:SWTX 9 January 2026

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Immunome shares rose 7.4% to $21.97 Friday after recent Phase 3 data showed its lead drug varegacestat cut disease progression or death by 84% in desmoid tumor patients. The company plans to file for FDA approval in Q2 2026. Immunome also granted stock options to three new hires and will present at the J.P. Morgan Healthcare Conference on Jan. 14.

Stock Market Today

  • Saul Centers' Series D Preferred Stock Yield Surpasses 7.5% Amid Price Drop
    March 20, 2026, 3:27 PM EDT. Shares of Saul Centers Inc's 6.125% Series D Cumulative Redeemable Preferred Stock (BFS.PRD) traded at yields above 7.5% on Friday, reaching a low price of $20.41. This yield contrasts with an 8.16% average in the "Real Estate" preferred stock sector, according to Preferred Stock Channel. BFS.PRD was trading at a 17.36% discount to its liquidation preference, deeper than the sector's 15.38% average discount. On the day, BFS.PRD and common shares (BFS) declined by about 0.8% and 1.2%, respectively. The higher yield reflects market price softness relative to its fixed dividend and suggests investor caution amid sector dynamics.
Go toTop